English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Nov 6, 2025

New studies reveal psychosocial impact of hereditary angioedema on youth
+ Pharmaceuticals
Patient Daily | Nov 6, 2025

Study links early onset and severity of childhood eczema with lower odds of overcoming food allergies
+ Pharmaceuticals
Patient Daily | Nov 6, 2025

Thunderstorms tied to spike in asthma ER visits according to new U.S. study
+ Pharmaceuticals
Patient Daily | Nov 6, 2025

Peanut patch therapy shows sustained safety and increased tolerance in toddlers after three years
+ Pharmaceuticals
Patient Daily | Nov 6, 2025

COVID-19 vaccine linked to fewer complications in children with eczema
+ Pharmaceuticals
Patient Daily | Nov 6, 2025

New studies link allergies and eczema to increased surgical complication risks
+ Pharmaceuticals
Patient Daily | Nov 6, 2025

Social media posts on allergies and asthma often popularize misinformation over facts
+ Pharmaceuticals
Patient Daily | Nov 6, 2025

ACAAI foundation grants highlight new approaches to overcoming barriers in allergy care

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes